John Valliant Fusion Pharmaceuticals Inc. (FUSN) insider trading activity

John Valliant is Chief Executive Officer of Fusion Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of FUSN, which is worth approximately $0. The most recent transaction as insider was on Jun 04, 2024, when has been sold 318,147 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

John Valliant Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2024	SELL Sale (or disposition) back to the issuer	-	318,147 Reduced 100.0%	0 Common Stock
Apr 27 2022	SELL Open market or private sale	$27,201 $6.03 p/Share	4,511 Reduced 1.4%	318,147 Common Stock
Apr 26 2022	SELL Open market or private sale	$13,032 $6.07 p/Share	2,147 Reduced 0.66%	322,658 Common Stock
Apr 25 2022	SELL Open market or private sale	$12,277 $6.03 p/Share	2,036 Reduced 0.62%	324,805 Common Stock
Apr 21 2022	SELL Open market or private sale	$5,541 $6.01 p/Share	922 Reduced 0.28%	326,841 Common Stock
Apr 20 2022	SELL Open market or private sale	$2,209 $6.02 p/Share	367 Reduced 0.11%	327,763 Common Stock
Apr 13 2022	SELL Open market or private sale	$76,882 $6.41 p/Share	11,994 Reduced 3.53%	328,130 Common Stock
Apr 12 2022	SELL Open market or private sale	$129,610 $7.1 p/Share	18,255 Reduced 5.09%	340,124 Common Stock
Apr 11 2022	SELL Open market or private sale	$19,162 $7.37 p/Share	2,600 Reduced 0.72%	358,379 Common Stock
Apr 08 2022	SELL Open market or private sale	$6,212 $7.52 p/Share	826 Reduced 0.23%	360,979 Common Stock
Apr 07 2022	SELL Open market or private sale	$9,488 $7.56 p/Share	1,255 Reduced 0.35%	361,805 Common Stock
Apr 06 2022	SELL Open market or private sale	$758 $7.58 p/Share	100 Reduced 0.03%	363,060 Common Stock
Apr 05 2022	SELL Open market or private sale	$16,107 $7.67 p/Share	2,100 Reduced 0.57%	363,160 Common Stock
Apr 04 2022	SELL Open market or private sale	$5,467 $7.81 p/Share	700 Reduced 0.19%	365,260 Common Stock
Apr 01 2022	SELL Open market or private sale	$7,750 $7.75 p/Share	1,000 Reduced 0.27%	365,960 Common Stock
Mar 30 2022	SELL Open market or private sale	$2,256 $7.52 p/Share	300 Reduced 0.08%	366,960 Common Stock
Mar 29 2022	SELL Open market or private sale	$1,504 $7.52 p/Share	200 Reduced 0.05%	367,260 Common Stock
Mar 28 2022	SELL Open market or private sale	$72,480 $7.55 p/Share	9,600 Reduced 2.55%	367,460 Common Stock
Mar 25 2022	SELL Open market or private sale	$3,710 $7.42 p/Share	500 Reduced 0.13%	377,060 Common Stock
Mar 23 2022	SELL Open market or private sale	$750 $7.5 p/Share	100 Reduced 0.03%	378,260 Common Stock
Mar 22 2022	SELL Open market or private sale	$30,120 $7.53 p/Share	4,000 Reduced 1.05%	378,360 Common Stock
Mar 21 2022	SELL Open market or private sale	$5,222 $7.46 p/Share	700 Reduced 0.19%	377,560 Common Stock
Mar 21 2022	SELL Open market or private sale	$11,205 $7.47 p/Share	1,500 Reduced 0.39%	382,360 Common Stock
Mar 18 2022	SELL Open market or private sale	$9,162 $7.61 p/Share	1,204 Reduced 0.31%	383,860 Common Stock
Mar 17 2022	SELL Open market or private sale	$6,759 $7.51 p/Share	900 Reduced 0.23%	385,064 Common Stock

John Valliant

Chief Executive Officer

Hamilton, A6

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FUSN shares.

Notify only if

Value

Insider Trading

Get notified when an Fusion Pharmaceuticals Inc. insider buys or sells FUSN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Fusion Pharmaceuticals Inc.

Track Activities on FUSN

Account